DCF — HILO MEDICAL CENTER
Enterprise Value: $-765.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-765.1M
Enterprise Value
$-235.1M
PV of Cash Flows
$-530.0M
PV of Terminal Value
$-853.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $271.5M | $-51.5M | -19.0% | $-63.0M | $-57.2M |
| Year 2 | $279.7M | $-50.2M | -18.0% | $-62.1M | $-51.3M |
| Year 3 | $288.1M | $-48.8M | -17.0% | $-61.0M | $-45.9M |
| Year 4 | $296.7M | $-48.8M | -16.0% | $-61.4M | $-41.9M |
| Year 5 | $305.6M | $-49.5M | -16.0% | $-62.5M | $-38.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-765.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$263.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.19453842675773578
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5